Cargando…

Long-term radiation therapy-related risk of second primary malignancies in patients with lung cancer

BACKGROUND: With the improvement of cancer therapy, a second primary malignancy (SPM) occurs more commonly among cancer survivors. At present, it remains unclear whether the radiation therapy for the initial lung cancer will increase the risk of developing a SPM. This study aims to investigate the l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Chang, Wu, Yijun, Kang, Kai, Wang, Zhile, Liu, Zhikai, Zhang, Fuquan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575836/ https://www.ncbi.nlm.nih.gov/pubmed/34795935 http://dx.doi.org/10.21037/jtd-21-915

Ejemplares similares

Second primary malignancies associated with radiation therapy in cervical cancer patients diagnosed between 1975 and 2011: a population-based competing-risk study
por: Wu, Yijun, et al.
Publicado: (2021)

Prognostic outcome after second primary lung cancer in patients with previously treated lung cancer by radiotherapy
por: Wu, Yijun, et al.
Publicado: (2020)

Role of chemotherapy for survival in patients with second primary non‐small cell lung cancer
por: Wang, Zhile, et al.
Publicado: (2020)

Prognostic study for survival outcome following the treatment of second primary lung cancer in patients with previously resected non‐small cell lung cancer
por: Wu, Yijun, et al.
Publicado: (2020)

Single-Cell Profiling Comparisons of Tumor Microenvironment between Primary Advanced Lung Adenocarcinomas and Brain Metastases and Machine Learning Algorithms in Predicting Immunotherapeutic Responses
por: Wu, Yijun, et al.
Publicado: (2023)

Second Malignant Neoplasms in Patients With Rhabdomyosarcoma
por: Zhen, Hongnan, et al.
Publicado: (2021)

Outcome of Non-small Cell Lung Cancer Patients With N3 Stage: Survival Analysis of Propensity Score Matching With a Validated Predictive Nomogram
por: Han, Chang, et al.
Publicado: (2021)

Exploration of potential novel drug targets and biomarkers for small cell lung cancer by plasma proteome screening
por: Wu, Yijun, et al.
Publicado: (2023)

A Population-Based Systematic Clinical Analysis With a Single-Center Case Series of Patients With Pulmonary Large Cell Neuroendocrine Carcinoma
por: Sun, Xu, et al.
Publicado: (2021)

Risk of developing second malignant neoplasms in patients with neuroblastoma: a population study of the US SEER database
por: Zhen, Hongnan, et al.
Publicado: (2021)

A blind randomized validated convolutional neural network for auto‐segmentation of clinical target volume in rectal cancer patients receiving neoadjuvant radiotherapy
por: Wu, Yijun, et al.
Publicado: (2021)

Carbon-ion radiotherapy in the treatment of radiation-induced second primary malignancies
por: Yang, Jing, et al.
Publicado: (2022)

Survival analysis of breast cancer patients after diagnosis of second primary malignancies, focusing on the second primary hematologic malignancy
por: Kim, Hyung Jin, et al.
Publicado: (2023)

Second Primary Malignancies and Myeloma Therapy: Fad or Fact?
por: Usmani, Saad Z.
Publicado: (2012)

Radiation Therapy Changed the Second Malignancy Pattern in Rectal Cancer Survivors
por: Ye, Xiaoxian, et al.
Publicado: (2023)

Ewing's Sarcoma as a Second Malignancy in Long-Term Survivors of Childhood Hematologic Malignancies
por: Wolpert, Fabian, et al.
Publicado: (2016)

Radiation-response in primary fibroblasts of long-term survivors of childhood cancer with and without second primary neoplasms: the KiKme study
por: Grandt, Caine Lucas, et al.
Publicado: (2022)

Mutational signatures of ionizing radiation in second malignancies
por: Behjati, Sam, et al.
Publicado: (2016)

Long-Term Control of Primary Cerebral ALH Amyloidoma With Focal Radiation Therapy
por: Shiao, Jay C., et al.
Publicado: (2021)

Long‐term outcomes of early stage oral tongue cancer: Main cause of treatment failure and second primary malignancy
por: Park, Young M., et al.
Publicado: (2022)

Long-term risk of second malignant neoplasm after a cancer in childhood.
por: de Vathaire, F., et al.
Publicado: (1989)

Risk prediction of second primary malignancies after gynecological malignant neoplasms resection with and without radiation therapy: a population-based surveillance, epidemiology, and end results (SEER) analysis
por: Wang, Jing, et al.
Publicado: (2023)

Primary pericardial malignant mesothelioma and response to radiation therapy
por: Reardon, Kelli A, et al.
Publicado: (2010)

Second primary malignancies after treatment for malignant lymphoma
por: Okines, A, et al.
Publicado: (2005)

Familial risk associated with lung cancer as a second primary malignancy in first-degree relatives
por: Ji, Jianguang, et al.
Publicado: (2022)

Clinical Outcomes of Patients with Resected Oral Cavity Cancer and Simultaneous Second Primary Malignancies
por: Liao, Chun-Ta, et al.
Publicado: (2015)

Second Primary Malignancies in Diffuse Large B-cell Lymphoma Survivors with 40 Years of Follow Up: Influence of Chemotherapy and Radiation Therapy
por: Rock, Calvin B., et al.
Publicado: (2022)

Clinical evaluation of stereotactic radiation therapy for recurrent or second primary mediastinal lymph node metastases originating from non-small cell lung cancer
por: Meng, Mao-Bin, et al.
Publicado: (2015)

Association between Long-Term Second Malignancy Risk and Radiation: A Comprehensive Analysis of the Entire Surveillance, Epidemiology, and End Results Database (1973-2014)
por: Wang, Chenyang, et al.
Publicado: (2019)

Second primary malignancies in thyroid cancer patients
por: Rubino, C, et al.
Publicado: (2003)

Second primary malignancies among cancer patients
por: Zheng, Xuanqi, et al.
Publicado: (2020)

Second primary malignancies in colorectal cancer patients
por: Halamkova, Jana, et al.
Publicado: (2021)

Risk Factors for Nonsynchronous Second Primary Malignancy and Related Death in Patients with Differentiated Thyroid Carcinoma
por: Lang, Brian Hung-Hin, et al.
Publicado: (2011)

Long-term follow up of patients with hematological malignancies treated with total body irradiation using intensity modulated radiation therapy
por: Ladbury, Colton, et al.
Publicado: (2022)

An Externally-Validated Dynamic Nomogram Based on Clinicopathological Characteristics for Evaluating the Risk of Lymph Node Metastasis in Small-Size Non-small Cell Lung Cancer
por: Wu, Yijun, et al.
Publicado: (2020)

Long-term population-based risks of second malignant neoplasms after childhood cancer in Britain
por: Jenkinson, H C, et al.
Publicado: (2004)

Life-long follow-up of second primary lung and extra-pulmonary cancer in lung cancer patients is needed
por: Ma, Bingqing, et al.
Publicado: (2020)

The Long-Term Effects of Therapy for Malignant Disease in Childhood
por: Jones, P. H. Morris
Publicado: (1980)

Dual Primary Cancer Patients With Lung Cancer as a Second Primary Malignancy: A Population-Based Study
por: Song, Congkuan, et al.
Publicado: (2020)

Synthesis of the second component of complement by long-term primary cultures of human monocytes
Publicado: (1976)

Cannot write session to /tmp/vufind_sessions/sess_ls8b20e26k9befcsph8ckcfqhe